Literature DB >> 19771278

Cell cycle regulatory protein expression profiles by adenovirus p53 infection in human papilloma virus-associated cervical cancer cells.

Yong-Seok Lee1, Su-Mi Bae, Sun-Young Kwak, Dong-Chun Park, Yong-Wook Kim, Soo-Young Hur, Eun-Kyung Park, Byoung-Don Han, Young-Joo Lee, Chong-Kook Kim, Do Kang Kim, Woong-Shick Ahn.   

Abstract

PURPOSE: The tumor suppressor gene, p53, has been established as an essential component for the suppression of tumor cell growth. In this study, we investigated the time-course anticancer effects of adenoviral p53 (Adp53) infection on human ovarian cancer cells to provide insight into the molecular-level understanding of the growth suppression mechanisms involved in Adp53-mediated apoptosis and cell cycle arrest.
MATERIALS AND METHODS: Three human cervical cancer cell lines (SiHa, CaSki, HeLa and HT3) were used. The effect of Adp53 infection was studied via cell count assay, cell cycle analysis, FACS, Western blot and macroarray assay.
RESULTS: Adp53 exerts a significant role in suppressing cervical cancer cell growth. Adp53 also showed growth inhibitory effects in each cell line, and it induced apoptosis and cell cycle arrest. Adp53 differentially regulated the expression of genes and proteins, and the gene expression profiles in the SiHa cells revealed that the p21, p53 and mdm2 expressions were significantly up-regulated at 24 and 48 hr. Western blot shows that the p21 and p53 expression-levels were significantly increased after Adp53 infection. In addition, in all cell lines, both the CDK4 and PCNA protein expression levels were decreased 48 h after Adp53 infection. Cell cycle arrest at the G1 phase was induced only in the SiHa and HeLa cells, suggesting that exogenous infection of Adp53 in cancer cells was significantly different from the other HPV-associated cervical cancer cells.
CONCLUSION: Adp53 can inhibit cervical cancer cell growth through induction of apoptosis and cell cycle arrest, as well as through the regulation of the cell cycle-related proteins. The Adp53-mediated apoptosis can be employed as an advanced strategy for developing preferential tumor cell-specific delivery.

Entities:  

Keywords:  Adenoviral p53; Apoptosis; Cervical cancer; Gene therapy; Growth arrest

Year:  2006        PMID: 19771278      PMCID: PMC2741675          DOI: 10.4143/crt.2006.38.3.168

Source DB:  PubMed          Journal:  Cancer Res Treat        ISSN: 1598-2998            Impact factor:   4.679


  24 in total

1.  Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1.

Authors:  J W Harbour; R X Luo; A Dei Santi; A A Postigo; D C Dean
Journal:  Cell       Date:  1999-09-17       Impact factor: 41.582

2.  Changes in p21WAF1, pRb, Mdm-2, Bax and Bcl-2 expression in cervical cancer cell lines transfected with a p53 expressing adenovirus.

Authors:  T G Huang; S M Ip; W S Yeung; H Y Ngan
Journal:  Eur J Cancer       Date:  2000-01       Impact factor: 9.162

3.  E2F mediates sustained G2 arrest and down-regulation of Stathmin and AIM-1 expression in response to genotoxic stress.

Authors:  Shirley Polager; Doron Ginsberg
Journal:  J Biol Chem       Date:  2002-11-21       Impact factor: 5.157

4.  Apoptosis associated with deregulated E2F activity is dependent on E2F1 and Atm/Nbs1/Chk2.

Authors:  Harry A Rogoff; Mary T Pickering; Fiona M Frame; Michelle E Debatis; Yolanda Sanchez; Stephen Jones; Timothy F Kowalik
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

Review 5.  p53 function and dysfunction.

Authors:  B Vogelstein; K W Kinzler
Journal:  Cell       Date:  1992-08-21       Impact factor: 41.582

6.  APAF-1 is a transcriptional target of p53 in DNA damage-induced apoptosis.

Authors:  A I Robles; N A Bemmels; A B Foraker; C C Harris
Journal:  Cancer Res       Date:  2001-09-15       Impact factor: 12.701

Review 7.  Biology of human papillomaviruses.

Authors:  H R McMurray; D Nguyen; T F Westbrook; D J McAnce
Journal:  Int J Exp Pathol       Date:  2001-02       Impact factor: 1.925

8.  Overexpression of the wild-type p53 gene inhibits NF-kappaB activity and synergizes with aspirin to induce apoptosis in human colon cancer cells.

Authors:  J Shao; T Fujiwara; Y Kadowaki; T Fukazawa; T Waku; T Itoshima; T Yamatsuji; M Nishizaki; J A Roth; N Tanaka
Journal:  Oncogene       Date:  2000-02-10       Impact factor: 9.867

9.  Recombinant adenovirus-p53 gene transfer and cell-specific growth suppression of human cervical cancer cells in vitro and in vivo.

Authors:  Woong Shick Ahn; Su Mi Bae; Keun Ho Lee; Joon Mo Lee; Sung Eun Namkoong; Heung Jae Chun; Chong Kook Kim; Yong-Wan Kim
Journal:  Gynecol Oncol       Date:  2004-02       Impact factor: 5.482

10.  Differential suppression of human cervical cancer cell growth by adenovirus delivery of p53 in vitro: arrest phase of cell cycle is dependent on cell line.

Authors:  Woong Shick Ahn; You Jin Han; Su Mi Bae; Tae-Hyung Kim; Min Seok Rho; Joon Mo Lee; Sung Eun Namkoong; Yong Seok Park; Chong Kook Kim; Jeong-Im Sin
Journal:  Jpn J Cancer Res       Date:  2002-09
View more
  2 in total

1.  Etoposide radiosensitizes p53-defective cholangiocarcinoma cell lines independent of their G2 checkpoint efficacies.

Authors:  Arunee Hematulin; Sutiwan Meethang; Kitsana Utapom; Sopit Wongkham; Daniel Sagan
Journal:  Oncol Lett       Date:  2018-01-09       Impact factor: 2.967

2.  Health-promoting bioactivity and in vivo genotoxicity evaluation of a hemiepiphyte fig, Ficus dubia.

Authors:  Uthaiwan Suttisansanee; Pornsiri Pitchakarn; Pisamai Ting; Woorawee Inthachat; Parunya Thiyajai; Daraphan Rodthayoy; Jirarat Karinchai; Bhanumas Chanatarasuwan; Onanong Nuchuchua; Piya Temviriyanukul
Journal:  Food Sci Nutr       Date:  2021-03-03       Impact factor: 2.863

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.